A Phase 2/3 Adaptive Double-blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of VX-147 in Subjects Adult and Pediatric subjects With APOL1-mediated Proteinuric Kidney Disease

Go Back to All Clinical Trials

A Phase 2/3 Adaptive Double-blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of VX-147 in Subjects Adult and Pediatric subjects With APOL1-mediated Proteinuric Kidney Disease

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

Conditions:
Apol1-mediated Proteinuric Kidney Disease
Age: Between 18 Year(s) - 60 Year(s)
Gender: Male or Female

Other Inclusion Criteria:
1. Diagnosed with chronic kidney disease.

You may not be eligible for this study if the following are true:

1. Participant has diabetes.
2. Ongoing participation in a clinical study (except Vertex genotyping VX19-NEN-801 study).

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies